Use of sphingolipids in the treatment of type 2 diabetes mellitus, insulin resistance and metabolic syndrome

作者: Aloysius Maria Havekes , Josephus Jan Emeis , Willem Ferdinand Nieuwenhuizen

DOI:

关键词:

摘要: The present invention relates to the use of sphingolipids for preparation a food item, supplement and/or medicament treatment insulin resistance, diabetes mellitus type 2 metabolic syndrome. In particular, sphingolipid with general formula (I): wherein Z is R3 or —CH(OH)—R3; A sulphate, sulphonate, phosphate, phosphonate —C(O)O—; R1 H, hydroxyl, alditol, aldose, an alcohol, C1-C6 alkyl amino acid; R2 H unsaturated saturated (C1-C30) chain; Q1 primary amine group (—NH2), secondary (—NH—) amide (—NH—CO—); and t 0 1, precursor, derivative pharmaceutically acceptable salt thereof, manufacture prevention disorder selected from consisting

参考文章(18)
Satoshi Nagaoka, Goro Hori, Iwao Sato, Kazuhiro Matsuoka, Lipid metabolism improving agent ,(2006)
Kenneth R. Feingold, Peter M. Elias, Carl R. Thornfeldt, Walter M. Holleran, Method and compositions for disrupting the epithelial barrier function ,(1994)
Dennis C. Liotta, Thomas E. Keane, Alfred H. Merrill, Eva M. Schmelz, Kapil N. Bhalla, Sphingolipid derivatives and their methods of use ,(1999)
Dennis C. Liotta, Alfred H. Merrill, Ronald T. Riley, Elaine W. Wang, Method of altering sphingolipid metabolism and detecting fumonisin ingestion and contamination Official Gazette of the United States Patent and Trademark Office Patents. ,vol. 1186, pp. 1979- 1980 ,(1992)
Stewart Paton Granger, Prem Chandar, Ian Richard Scott, Stable skin care compositions containing a retinoid and a retinoid booster system ,(2001)
Kevin Jon Williams, Michael J. Hope, Wendi V. Rodrigueza, Liposomal compositions, and methods of using liposomal compositions to treat dislipidemias ,(2001)
Victoria L. Stevens, Joseph M. Kinkade, Alfred H. Merrill, Method of modifying cellular differentiation and function and compositions therefor ,(1989)